VIGAFYDE Trademark

Trademark Overview

On Thursday, August 24, 2023, a trademark application was filed for VIGAFYDE with the United States Patent and Trademark Office. The USPTO has given the VIGAFYDE trademark a serial number of 98149022. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, June 30, 2025. This trademark is owned by Pyros Pharmaceuticals, Inc.. The VIGAFYDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system disorders
vigafyde

General Information

Serial Number98149022
Word MarkVIGAFYDE
Filing DateThursday, August 24, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, June 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 4, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 25, 2023
Primary Code005
First Use Anywhere DateMonday, August 26, 2024
First Use In Commerce DateMonday, August 26, 2024

Trademark Owner History

Party NamePyros Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NamePyros Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Monday, August 28, 2023NEW APPLICATION ENTERED
Monday, September 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 27, 2023LETTER OF PROTEST EVIDENCE FORWARDED
Sunday, April 21, 2024ASSIGNED TO EXAMINER
Thursday, April 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 25, 2024LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Tuesday, June 4, 2024PUBLISHED FOR OPPOSITION
Wednesday, May 15, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 14, 2024OPPOSITION PAPERS RECEIVED AT TTAB
Friday, December 20, 2024OPPOSITION DISMISSED NO. 999999
Tuesday, January 28, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 14, 2024OPPOSITION INSTITUTED NO. 999999
Friday, December 20, 2024OPPOSITION TERMINATED NO. 999999
Friday, December 20, 2024TTAB RELEASE CASE TO TRADEMARKS
Tuesday, January 28, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 28, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 26, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, June 28, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, June 30, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 30, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, June 28, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 26, 2025USE AMENDMENT FILED

Related Keywords

vigafyde system disorders nervous central preparations treatment pharmaceutical